What GLP-1 Drugs Like Ozempic Actually Do to Your Brain, Heart and Metabolism
A leading GLP-1 researcher reveals what Ozempic and Mounjaro really treat, their benefits beyond weight loss, and how to use them safely.
396 articles in this topic
A leading GLP-1 researcher reveals what Ozempic and Mounjaro really treat, their benefits beyond weight loss, and how to use them safely.
Gastroenterologist Dr. Giulia Enders reveals why immune balance — not strength — is the real key to health and longevity.
Allergies have tripled. A leading immunologist explains the gut-immune connection driving the surge and what you can do about it.
Bacteriophages — viruses living in your gut — could fight deadly infections, protect your microbiome, and even target cancer cells.
Science writer Michael Pollan and Prof. Tim Spector break down why junk food is engineered to override fullness and drive cravings.
A leading microbiologist breaks down which mushroom health claims hold up, which don't, and the cooking mistake undercutting your results.
Psychiatrist Ed Bullmore reveals how body-wide inflammation may alter brain function, mood, and dementia risk — and what to do about it.
GLP-1 drugs shrink appetite but risk muscle loss and nutrient gaps. Here's what to eat before, during, and after treatment.
Prof Tim Spector, Prof Sarah Berry and Dr Federica Amati answer top nutrition questions on gut health, dementia risk, fasting and UPFs.
New mouse research shows gut bacteria preserve egg supply via short-chain fatty acids, opening a dietary path to extended female fertility.
Nano-sized vesicles from a depleted gut bacterium rebalance immune cells and antibody transport in colitis, with taurine as the key metabolic link.
A novel gut microbiome metabolite chemically modifies liver proteins, impairing mitochondrial function and insulin signaling in obesity and fatty liver disease.